Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer.

Explor Target Antitumor Ther · 2020 · PMC9400697 · PMID 36046069

Europe PMC DOI

hedged sentence

0.0920

closest p · 1.8× alpha

0.0920

boldest claim

The sentences

a positive trendP = 0.092so close (0.05 < p ≤ 0.1)

No difference in PFS (4.2 versus 4.6 months for EB and PGB, respectively) and only a positive trend for OS (17.0 versus 10.0 months, for EB and PGB, respectively; HR 0.45, 95% CI: 0.18–1.16, P = 0.092) were observed.

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.